NOT_YET_RECRUITING

Decision Aid for Dementia Therapies

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to develop a decision aid to support patients and families making decisions about medications for dementia.

Official Title

Helping Patients, Families, and Clinicians Make Shared Decisions About Therapies for Dementia

Quick Facts

Study Start:2025-11
Study Completion:2026-02-28
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:NOT_YET_RECRUITING

Study ID

NCT06638632

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * UCHealth patient
  2. * Ages 18 y/o and above
  3. * Documented neurocognitive deficits suggestive of mild cognitive impairment or early dementia as determined by their treating clinician.
  4. * English or Spanish speaking
  5. * Ages 18 y/o and above
  6. * Identified by the study participant as the person who helps the most with their medical care outside the hospital or clinic.
  7. * English or Spanish speaking
  8. * Neurologists, primary care clinicians, pharmacists, or psychologists involved in dementia decision-making.
  9. * English or Spanish speaking
  1. * Not English or Spanish-speaking
  2. * Neurocognitive deficits suggestive of moderate or severe cognitive impairment or late stage dementia.
  3. * Not able to consent for themselves
  4. * Ages 17 y/o and below
  5. * Not English or Spanish-speaking
  6. * Neurologists, primary care clinicians, pharmacists, or psychologists involved in dementia decision-making.
  7. * English or Spanish-speaking

Contacts and Locations

Study Contact

Kaitlynn Walton, MPH
CONTACT
303-724-7162
kaitlynn.walton@cuanschutz.edu
Kate Noonan, MSW
CONTACT
303-618-2181
kate.noonan@cuanschutz.edu

Principal Investigator

Dan Matlock, MD, MPH
PRINCIPAL_INVESTIGATOR
University of Colorado, Denver

Study Locations (Sites)

University of Colorado
Aurora, Colorado, 80045
United States

Collaborators and Investigators

Sponsor: University of Colorado, Denver

  • Dan Matlock, MD, MPH, PRINCIPAL_INVESTIGATOR, University of Colorado, Denver

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-11
Study Completion Date2026-02-28

Study Record Updates

Study Start Date2025-11
Study Completion Date2026-02-28

Terms related to this study

Keywords Provided by Researchers

  • Lecanemab

Additional Relevant MeSH Terms

  • Dementia
  • Decision Aids